Top Markets
#1 DogBull DogBull +75.07%
#2 Siren Siren +31.73%
#3 Verus Coin Verus Coin +18.65%
#4 OriginTrail OriginTrail +14.62%
#5 龙虾 (Lobster) 龙虾 (Lobster) +11.73%
#6 Tutorial Tutorial +7.87%
#7 COTI COTI +7.71%
#8 Unit Pump Unit Pump +7.21%
#9 Pump.fun Pump.fun +7.21%
#10 PulseChain PulseChain +6.89%
Coin of the day
DogBull DogBull
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Brii Biosciences Limited Brii Biosciences Limited

Brii Biosciences Limited

2137
Classifica tra le azioni #22138
Founded in Beijing, China, in 2017, Brii Biosciences Limited is a... Founded in Beijing, China, in 2017, Brii Biosciences Limited is a biopharmaceutical firm dedicated to discovering and developing innovative therapies for infectious diseases and central nervous system disorders. Its diverse pipeline features: early-stage (Phase 1) compounds BRII-778 and BRII-732 for treating HIV; a multifaceted approach to Hepatitis B (HBV) including a Phase 2 combination study of BRII-179 and BRII-835, with BRII-179 (a recombinant protein-based immunotherapeutic) also in Phase 1b/2a, and BRII-835 having successfully completed Phase 2 for chronic HBV patients. The company also offers the Amubarvimab/romlusevimab combination as a treatment for COVID-19. Beyond these, Brii Biosciences is advancing BRII-296 for PPD and BRII-297 for various depressive conditions, alongside several agents targeting highly resistant infections: BRII-636, BRII-672, and BRII-693 are designed to combat multi-drug and extensively drug-resistant (MDR/XDR) gram-negative bacteria, while BRII-658 is under development for MDR/XDR tuberculosis and non-tuberculosis mycobacterial infections.
Prezzo delle azioni
$0.12984512
Ultima sincronizzazione: 2026-08-21
Capitalizzazione di mercato
$93.64M
Variazione (1 giorno)
3.57%
Variazione (1 anno)
-49.27%
Paese
CN
Scambia Brii Biosciences Limited (2137)

Categoria

Healthcare
Rapporto P/B per Brii Biosciences Limited (2137)
Rapporto P/B al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Brii Biosciences Limited, il rapporto P/B attuale (TTM) è 0. Alla fine del 2026, era pari a 0.
Storico del rapporto P/B per Brii Biosciences Limited da 2026 a 2026
Rapporto P/B alla fine di ogni anno
Anno Rapporto P/B Cambia
Non abbastanza dati per le date fornite.
Rapporto P/B per aziende simili o concorrenti
Azienda Rapporto P/B Differenza del rapporto P/B Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH